What We Do

Our main research focus is to improve patient outcomes by gaining deeper understanding of lymphoma biology and disease progression which can be translated into clinical applications. Our ultimate goal is to improve patient outcomes through enhanced precision medicine, which can be designed using advanced genomic tools.

News & Events

Jun 20, 2023

Research reveals insights into lymphoma relapse and treatment response

A recent study conducted by researchers at BC Cancer has shed light on the cause behind the different outcomes of patients with diffuse large B-cell lymphoma (DLBCL) who experience a relapse of their disease. The study, led by Dr. Laura Hilton, staff scientist at BC Cancer’s Centre for Lymphoid Cancer (CLC), and Dr. David Scott, clinical director of the CLC, aimed to understand the molecular characteristics of the initial diagnostic and relapse tumour samples of patients with DLBCL.

Dec 05, 2022

BCCF Innovation Support Fund Awardees

The BCCF Innovation Support Fund Awardees are:

  • Ly Vu & Christian Steidl - equipment: Bio-Rad ChemiDoc Imaging System
  • Pamela Hoodless - equipment: Thermo EVOS M5000 Cell Imaging Microscope

The BC Cancer Foundation, in partnership with BC Cancer, established the Innovation Support Fund competition in 2010 to enable the acquisition of equipment essential to conducting research. 

Jul 08, 2020

Dr. David Scott named to Lymphoma Research Foundation scientific advisory board

The Lymphoma Research Foundation (LRF) is the largest non-profit lymphoma research organization in North America with a volunteer scientific advisory board comprised of world-renowned lymphoma experts, including Dr. David Scott. Dr. Scott is the clinical director of the BC Cancer Centre for Lymphoid Cancer, deputy head of the BC Cancer Lymphoid Cancer Research and an associate professor at the University of British Columbia. Dr.

Research Labs & Principal Investigators

Recent Publications

Genomic Profiling for Clinical Decision Making in Lymphoid Neoplasms

Blood, 2022
Laurence de Leval, Ash A Alizadeh, P Leif Bergsagel, Elias Campo, Andrew John Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M. Horwitz, Ari M. Melnick, William George Morice, Ryan D Morin, Bertrand Nadel, Stefano A Pileri, Professor, Richard Rosenquist, Davide Rossi, Itziar Salaverria, Christian Steidl, Steven P Treon, Andrew D. Zelenetz, Ranjana Advani, Carl E Allen, Stephen M. Ansell, Wing C. Chan, James R. Cook, Lucy B Cook, Francesco d'Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew Feldman, Falko Fend, Philippe GAULARD, Paolo Ghia, John G Gribben, Olivier Hermine, Daniel J Hodson, Eric D. Hsi, Giorgio GA Inghirami, Elaine S. Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfram Klapper, Won Seog Kim, Rebecca L King, Young Hyeh Ko, Ann S. LaCasce, Georg Lenz, Iñaki Martin-Subero, Miguel A Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla-Martinez, Scott J. Rodig, Andreas Rosenwald, Gilles A. Salles, Jesus San-Miguel, Kerry J. Savage, Laurie H. Sehn, Gianpietro Semenzato, Louis M Staudt, Steven Howard Swerdlow, Constantine S. Tam, Judith Trotman, Julie Vose, Oliver Weigert, Wyndham H. Wilson, Jane N Winter, Catherine J. Wu, Pier Luigi Zinzani, Emanuele Zucca, Adam Bagg, David W. W. Scott

Molecular Determinants of Clinical Outcomes In a Real-World Diffuse Large B-cell Lymphoma Population

Blood, 2022
Waleed Alduaij, Brett J Collinge, Susana Ben-Neriah, Aixiang Jiang, Laura K Hilton, Merrill Boyle, Barbara Meissner, Lauren C. Chong, Tomoko Miyata-Takata, Graham W. Slack, Pedro Farinha, Jeffrey W Craig, Andrew Lytle, Kerry J. Savage, Diego Villa, Alina S. Gerrie, Ciara L. Freeman, Randy D. Gascoyne, Joseph M Connors, Ryan D Morin, Laurie H. Sehn, Andrew J Mungall, Christian Steidl, David W. Scott
Back to top